COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,510 Articles (22,870 medRxiv, 8,640 bioRxiv)

Most recent first Previous |  Page 2190: Articles 21891-21900  | Next

Innate lymphoid cell composition associates with COVID-19 disease severity
Garcia, M., Kokkinou, E., Carrasco Garcia, A., Parrot, T., Palma Medina, L. M., Maleki, K. T., Christ, W., Varnaite, R., Filipovic, I., Ljunggren, H.-G., Bjorkstrom, N. K., Folkesson, E., Rooyackers, O., Eriksson, L. I., Sonnerborg, A., Aleman, S., Stralin, K., Gredmark-Russ, S., Klingstrom, J., Mjosberg, J., the Karolinska KI/K COVID-19 Study Group
10.1101/2020.10.13.20211367 — Posted: 2020-10-14
Frequent testing regimen based on salivary samples for an effective COVID-19 containment strategy
Plebani, M., Aita, A., Cattelan, A. M., Bonfante, F., Padoan, A., Giaquinto, C., Basso, D.
10.1101/2020.10.13.20210013 — Posted: 2020-10-14
Virus detection and identification in minutes using single-particle imaging and deep learning
Shiaelis, N., Tometzki, A., Peto, L., McMahon, A., Hepp, C., Bickerton, E., Favard, C., Muriaux, D., Andersson, M., Oakley, S., Vaughan, A., Matthews, P. C., Stoesser, N., Crook, D., Kapanidis, A. N., Robb, N. C.
10.1101/2020.10.13.20212035 — Posted: 2020-10-14 Discussion: Onsite
Dynamic dysregulation of IL-6 and genes functional in NETosis, complement and coagulation in severe COVID-19 illness
Mukhopadhyay, S., Sinha, S., Mohapatra, S. K.
10.1101/2020.10.13.20211425 — Posted: 2020-10-14
Circulating Proteins Influencing COVID-19 Susceptibility and Severity: a Mendelian Randomization Study
Zhou, S., Butler-Laporte, G., Nakanishi, T., Morrison, D., Afilalo, J., Afilalo, M., Kimchi, N., Afrasiabi, Z., Rezk, N., Bouab, M., Guzman, C., Petitjean, L., Xue, X., Tselios, C., Vulesevic, B., Chen, Y., Mooser, V., Forgetta, V., Kaufmann, D., Richards, B.
10.1101/2020.10.13.20212092 — Posted: 2020-10-14
Does autism protect against COVID quarantine effects?
Guidotti, M., Gateau, A., Malvy, J., Bonnet-Brilhault, F.
10.1101/2020.10.13.20212118 — Posted: 2020-10-14
Nonspecific blood tests as proxies for COVID-19 hospitalization: are there plausible associations after excluding noisy predictors?
Ishikawa, G., Argenti, G., Fadel, C. B.
10.1101/2020.10.12.20211557 — Posted: 2020-10-14
Precautionary breaks: planned, limited duration circuit breaks to control the prevalence of COVID-19
Keeling, M. J., Guyver-Fletcher, G., Holmes, A., Dyson, L. J., Tildesley, M., Hill, E. M., Medley, G. F.
10.1101/2020.10.13.20211813 — Posted: 2020-10-14
Symptom-based testing in a compartmental model of COVID-19
Bartha, F. A., Karsai, J., Tekeli, T., Röst, G.
10.1101/2020.10.11.20211037 — Posted: 2020-10-14
What is the evidence for transmission of COVID-19 by children in schools? A living systematic review
Xu, W., Li, X., Dozier, M., He, Y., Kirolos, A., Lang, Z., Mathews, C., Siegfried, N., Theodoratou, E.
10.1101/2020.10.11.20210658 — Posted: 2020-10-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).